Florence Guimberteau
24Patents
10h-index
15Co-inventors
72Inventor score
Filing activity: Jan 28, 2000 → Apr 11, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8445023B2 | Anti-misuse microparticulate oral pharmaceutical form | Human Necessities | 89 | Active |
| US7906145B2 | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | Human Necessities | 87 | Expired |
| US8652529B2 | Anti-misuse microparticulate oral pharmaceutical form | Human Necessities | 76 | Active |
| US9023400B2 | Prolonged-release multimicroparticulate oral pharmaceutical form | Human Necessities | 50 | Active |
| US8821935B2 | Microcapsules with modified release of active principles with low solubility for oral delivery | Human Necessities | 40 | Active |
| US8652523B2 | Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility | Human Necessities | 40 | Expired |
| US8734850B2 | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | Human Necessities | 37 | Active |
| US9814684B2 | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | Human Necessities | 34 | Active |
| USRE47084E1 | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | General | 34 | Active |
| US10004693B2 | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | Human Necessities | 34 | Active |
| US8895063B2 | Oral dosage form comprising an antimisuse system | Human Necessities | 9 | Active |
| US7910133B2 | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin | Human Necessities | 5 | Expired |
| US11331321B2 | Triazine formulations with a second active ingredient and surfactant(s) | Emerging Cross-Sectional Technologies | 3 | Active |
| US6602917B1 | Method for preparing concentrated and emulsions calibrated in a highly viscous phase, in particular bitumen emulsions | Emerging Cross-Sectional Technologies | 2 | Expired |
| US11020350B2 | Palatable oral veterinary compositions | Human Necessities | 0 | Active |
| US11872208B2 | Composition for treating parasites infestations | Human Necessities | 0 | Active |
| US11318156B2 | Solid injectable veterinary implants comprising monocyclic lactone | Human Necessities | 0 | Active |
| US11911391B2 | Triazine formulations with a second active ingredient and surfactant(s) | Emerging Cross-Sectional Technologies | 0 | Active |
| US11903947B2 | Triazine formulations with a second active ingredient and surfactant(s) | Emerging Cross-Sectional Technologies | 0 | Active |
| US12342792B2 | Nose ring for ruminants | Human Necessities | 0 | Active |
| US11903946B2 | Triazine formulations with a second active ingredient and surfactant(s) | Emerging Cross-Sectional Technologies | 0 | Active |
| US12257226B2 | Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals | Human Necessities | 0 | Active |
| USD1065719S1 | Nose ring for animals | General | 0 | Active |
| US11090270B2 | Palatable oral veterinary compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.